返回 Agenda
Session Chair(s)
Tatsuo Kurokawa, DIAFellow, PHD
Director General
The Japan Biosimilar Association, Japan
Speaker(s)
Sandra Milliagan presentation
Sandy Milligan, JD, MD
Innovex Strategies, United States
Board of Director Member, Gossamer Bio; Principal
Haruhisa Hirosaki presentation
Haruhisa Hirosaki
Astellas Pharma Inc., Japan
Executive Vice President, Head of Japan-Asia Development, Global Development
Hiromichi Shirasawa presentation
Hiromichi Shirasawa, MD
MSD K.K., Japan
Vice President and Executive Officer, Head of Japan Development
Dalvir Gill presentation
Dalvir Gill, PHD
TransCelerate BioPharma Inc., United States
Chief Executive Officer
Daisaku Sato presentation
Daisaku Sato, PHD, MPHARM, RPH
Ministry of Health, Labour and Welfare, Japan
Councilor for Pharmaceutical Affairs